Selected EMA news, April 2025

New medicines recommended for approval

• Xoanacyl (ferric citrate coordination complex)
  Treatment of concomitant hyperphosphatemia and iron deficiency in adults with chronic kidney disease

New information on approved medicines

• Bosulif (bosutinib) – extension of indication and new pharmaceutical form
  Treatment of myeloid leukemia (blood cancer)
• Calquence (acalabrutinib) – new indication
  Treatment of lymphoma and leukemia (blood cancers)

Negative CHMP opinions on extension of indication

• Pemazyre (pemigatinib)
  Intended to treat myeloid/lymphoid neoplasms (blood cancers)